GSK-Pfizer consumer healthcare joint venture wins EU approval
MLex Summary: GlaxoSmithKline and Pfizer’s plan to combine their consumer-healthcare businesses in a joint venture has been cleared by the European Commission, after the companies agreed to divest Pfizer’s “topical pain...To view the full article, register now.
Already a subscriber? Click here to view full article